The use of pre- pro- and synbiotics in adult intensive care unit patients: Systematic review

Clinical Nutrition

Volumn 26, Issue 2, 2007, Pages 182-192

  Watkinson, Peter J ^a   Barber, Vicki S ^a   Dark, Paul ^b   Young, J Duncan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Meta analysis; Nutrition; Pneumonia; Prevention; Probiotic; Systematic review

Indexed keywords

BETA GLUCAN; BIFIDOBACTERIUM ANIMALIS EXTRACT; BIFIDOBACTERIUM BREVE EXTRACT; FRUCTOSE; INULIN; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOBACILLUS BULGARICUS EXTRACT; LACTOBACILLUS CASEI EXTRACT; LACTOBACILLUS PARACASEI EXTRACT; LACTOBACILLUS PLANTARUM EXTRACT; LACTOCOCCUS RAFFINOLACTIS EXTRACT; LEUCONOSTOC MESENTEROIDES EXTRACT; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; NATURAL PRODUCT; OLIGOSACCHARIDE; PECTIN; PEDIACOCCUS PENTOSECEUS EXTRACT; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; PROVIVA; RAFTILOSE; STARCH; STREPTOCOCCUS THERMOPHILUS EXTRACT; SYNBIOTIC 2000; SYNBIOTIC AGENT; TREVIS; UNCLASSIFIED DRUG;

BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICALLY ILL PATIENT; DIETARY FIBER; ENTERIC FEEDING; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOCOCCUS RAFFINOLACTIS; LENGTH OF STAY; LEUCONOSTOC MESENTEROIDES; MORTALITY; PEDIACOCCUS PENTOSECEUS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS THERMOPHILUS; SURGICAL INFECTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CRITICAL ILLNESS; CROSS INFECTION; ENTERAL NUTRITION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; LENGTH OF STAY; PNEUMONIA; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS;

EID: 33947716253     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.07.010     Document Type: Review

References (54)

1. Inan D., Saba R., Gunseren F., et al. Daily antibiotic cost of nosocomial infections in a Turkish University Hospital. BMC Infect Dis 5 (2005) 5
2. Sanchez Garcia M., Cambronero Galache J.A., Lopez Diaz J., et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158 (1998) 908-916
3. Deitch E.A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 125 (1990) 403-404
4. MacFie J., O'Boyle C., Mitchell C.J., Buckley P.M., Johnstone D., and Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45 (1999) 223-228
5. Safdar N., Crnich C.J., and Maki D.G. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 50 (2005) 725-739
6. D'Amico R., Pifferi S., Leonetti C., Torri V., Tinazzi A., and Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 316 (1998) 1275-1285
7. Vincent J.L. Nosocomial infections in adult intensive-care units. Lancet 361 (2003) 2068-2077
8. Lin H.C., Su B.H., Chen A.C., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 (2005) 1-4
9. Bin-Nun A., Bromiker R., Wilschanski M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147 (2005) 192-196
10. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., and Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354 (1999) 635-639
11. Furrie E., Macfarlane S., Kennedy A., et al. Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54 (2005) 242-249
12. Mimura T., Rizzello F., Helwig U., et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 (2004) 108-114
13. Roberfroid M.B. Prebiotics: preferential substrates for specific germs?. Am J Clin Nutr 73 (2001) 406S-409S
14. Schrezenmeir J., and de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 73 (2001) 361S-364S
15. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
16. Gomersall CD, Joynt GM, Leung P, Tan P, Bengmark S. Does routine administration of probiotics improve outcome of critically ill patients? ANZCA ASM 2006.
17. Klarin B., Johansson M.L., Molin G., Larsson A., and Jeppsson B. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care 9 (2005) R285-R293
18. Jain P.K., McNaught C.E., Anderson A.D., MacFie J., and Mitchell C.J. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 23 (2004) 467-475
19. Kanazawa H., Nagino M., Kamiya S., et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390 (2005) 104-113
20. McNaught C.E., Woodcock N.P., Anderson A.D., and MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 24 (2005) 211-219
21. Rayes N., Hansen S., Seehofer D., et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18 (2002) 609-615
22. Rayes N., Seehofer D., Theruvath T., et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial. Am J Transplant 5 (1995) 125-130
23. Olah A., Belagyi T., Issekutz A., Gamal M.E., and Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89 (2002) 1103-1107
24. McNaught C.E., Woodcock N.P., MacFie J., and Mitchell C.J. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 51 (2002) 827-831
25. Anderson A.D., McNaught C.E., Jain P.K., and MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53 (2004) 241-245
26. Rushdi T.A., Pichard C., and Khater Y.H. Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial. Clin Nutr 23 (2004) 1344-1352
27. Spapen H., Diltoer M., Van Malderen C., Opdenacker G., Suys E., and Huyghens L. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial. Clin Nutr 20 (2001) 301-305
28. de Felippe Junior J., da Rocha e Silva Junior M., Maciel F.M., Soares Ade M., and Mendes N.F. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). Surg Gynecol Obstet 177 (1993) 383-388
29. Falcao de Arruda I.S., and de Aguilar-Nascimento J.E. Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin Sci (London) 106 (2004) 287-292
30. Voudouris A., Kazamias P., Spyridaki E., et al. Benefits of Synbiotic 2000 Forte in critically ill patients: a randomized controlled trial. Crit Care 9 (2005) P362
31. Shimizu K., Hiroshi O., Goto M., et al. Synbiotics reduce the septic complications in patients with severe SIRS. Crit Care Med 33 (2005) A9
32. Rayes N., Seehofer D., Muller A.R., Hansen S., Bengmark S., and Neuhaus P. Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery-results of a prospective trial. Z Gastroenterol 40 (2002) 869-876
33. Torres A., el-Ebiary M., Gonzalez J., et al. Gastric and pharyngeal flora in nosocomial pneumonia acquired during mechanical ventilation. Am Rev Respir Dis 148 (1993) 352-357
34. Ewig S., Torres A., El-Ebiary M., et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 159 (1999) 188-198
35. Park D.R. The microbiology of ventilator-associated pneumonia. Respir Care 50 (2005) 742-763
36. DeRiso III A.J., Ladowski J.S., Dillon T.A., Justice J.W., and Peterson A.C. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 109 (1996) 1556-1561
37. Mori H., Hirasawa H., Oda S., Shiga H., Matsuda K., and Nakamura M. Oral care reduces incidence of ventilator-associated pneumonia in ICU populations. Intens Care Med 32 (2006) 230-236
38. Bergmans D.C., Bonten M.J., Gaillard C.A., et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 164 (2001) 382-388
39. Johanson Jr. W.G., Pierce A.K., Sanford J.P., and Thomas G.D. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 77 (1972) 701-706
40. Hussain T., Roy U., and Young P.J. The incidence and immediate respiratory consequences of pulmonary aspiration of enteral feed as detected using a modified glucose oxidase test. Anaesth Intens Care 31 (2003) 272-276
41. Metheny N.A., Clouse R.E., Chang Y.-H., Stewart B.J., Oliver D.A., and Kollef M.H. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: Frequency, outcomes, and risk factors. Crit Care Med 34 (2006) 1007-1015
42. Torres A., El-Ebiary M., Soler N., Monton C., Fabregas N., and Hernandez C. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia. Eur Respir J 9 (1996) 1729-1735
43. Heyland D., and Mandell L.A. Gastric colonization by Gram-negative bacilli and nosocomial pneumonia in the intensive care unit patient. Evidence for causation. Chest 101 (1992) 187-193
44. Niederman M.S., and Craven D.E. Devising strategies for preventing nosocomial pneumonia--should we ignore the stomach?. Clin Infect Dis 24 (1997) 320-323
45. Bonten M.J., Gaillard C.A., de Leeuw P.W., and Stobberingh E.E. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis 24 (1997) 309-319
46. Cook D., Guyatt G., Marshall J., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338 (1998) 791-797
47. Drakulovic M.B., Torres A., Bauer T.T., Nicolas J.M., Nogue S., and Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354 (1999) 1851-1858
48. Gluck U., and Gebbers J.O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77 (2003) 517-520
49. Martins F.S., Nardi R.M., Arantes R.M., Rosa C.A., Neves M.J., and Nicoli J.R. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 51 (2005) 83-92
50. Senok A.C., Ismaeel A.Y., and Botta G.A. Probiotics: facts and myths. Clin Microbiol Infect 11 (2005) 958-966
51. Rioux K.P., and Fedorak R.N. Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 40 (2006) 260-263
52. Lherm T., Monet C., Nougiere B., et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intens Care Med 28 (2002) 797-801
53. Rautio M., Jousimies-Somer H., Kauma H., et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28 (1999) 1159-1160
54. Land M.H., Rouster-Stevens K., Woods C.R., Cannon M.L., Cnota J., and Shetty A.K. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 (2005) 178-181